1. Comparison of the indirect immunofluorescence assay and a commercial ELISA to detect KSHV antibodies.
- Author
-
Leducq V, Ben Said L, Sayon S, Calvez V, Marcelin A-G, and Jary A
- Subjects
- Humans, Fluorescent Antibody Technique, Indirect methods, Sarcoma, Kaposi diagnosis, Sarcoma, Kaposi virology, Sarcoma, Kaposi immunology, Female, Male, Middle Aged, Adult, HIV Infections diagnosis, HIV Infections virology, HIV Infections immunology, Herpesvirus 8, Human immunology, Herpesvirus 8, Human isolation & purification, Enzyme-Linked Immunosorbent Assay methods, Antibodies, Viral blood, Sensitivity and Specificity, Herpesviridae Infections diagnosis, Herpesviridae Infections virology, Herpesviridae Infections immunology
- Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) is an oncogenic virus involved in several diseases. The gold standard for KSHV sero diagnosis remains the indirect immunofluorescence assay (IFA), which is time-consuming and operator-dependent. We compared this method with an enzyme-linked immunosorbent assay (ELISA) targeting solubilized KSHV whole-genome extract among positive ( n = 49, including 76% of HIV-infected patients) and negative ( n = 14) control groups. We also included 14 sera with equivocal IFA results. ELISA showed better performance in detecting KSHV antibodies (McNemar's test, P = 0.0455). The sensitivity and specificity of both methods were 79% (64-89) and 100% (66-100) for the IFA, respectively, and 94% (83-99) and 100% (66-100) for ELISA, respectively. All IFA equivocal results were either negative or positive with ELISA. ELISA is more reliable and could be a good alternative for determining KSHV serological status, particularly in the context of immunocompromised patients and equivocal serology with the IFA.IMPORTANCEKaposi's sarcoma-associated herpesvirus (KSHV) sero status remains challenging because no perfect reference is available for the detection of KSHV antibodies. The current gold-standard method, the indirect immunofluorescence assay (IFA), has a very good specificity of close to 100%, but a lower sensitivity of around 80-85%, which decreases to 64-67% in immunocompromised patients. Additionally, this method is time-consuming and operator-dependent compared with new serological assays such as the enzyme-linked immunosorbent assay (ELISA). Thus, further research is still needed to improve KSHV sero diagnosis. Here, we compare the KSHV IgG ELISA kit assay (Advanced Biotechnologies Inc) with the gold-standard IFA, targeting the LANA-1 protein from latent BC-3 cell lines., Competing Interests: The authors declare no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF